Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens
Crossref DOI link: https://doi.org/10.1186/2193-1801-3-259
Published Online: 2014-05-21
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hansen, Ryan N
Ramsey, Scott D
Lalla, Deepa
Masaquel, Anthony
Kamath, Tripthi
Brammer, Melissa
Hurvitz, Sara A
Sullivan, Sean D
Text and Data Mining valid from 2014-05-21
Article History
Received: 14 May 2014
Accepted: 15 May 2014
First Online: 21 May 2014